Please join us Thursday, April 2nd from 1-2 PM EST to listen to the LIVE panel, COVID 19: Strategic Implications on Biopharma. Following our COVID-19 thought leadership piece on the strategic implications for biopharma, our panelists look forward to taking a deeper dive in the following:

• Lessons for biopharma from the 2001 and 2008 financial crisis
• Biopharma strategy in this turbulent financial environment
• Capital markets turmoil and how to navigate
• Venture capital landscape for new funding
• Strategic dealmaking anticipated trends

Introducing our panelists (from left to right):
Geoff Meyerson, CEO & Co-Founder, Locust Walk
Chris Ehrlich, Senior Managing Director, Global Head of Biopharma, Locust Walk
Brian Coleman, Managing Director, Global Head of Financing and Sales, Locust Walk
Timothy Ehrlich, Partner, Gunderson Dettmer